Investors anticipate a DEA decision on rescheduling marijuana, driving a rally in cannabis stocks. U.S. MSOs like AdvisorShares Pure US Cannabis ETF have surged ~49%, with other related ETFs also gaining. Expert Adrian Snead suggests a possible rescheduling decision, potentially impacting companies like MedMen Enterprises and Canopy Growth. Senate Democrats advocate for marijuana descheduling.
Read the full story here
Written by:
Published on February 7, 2024 at 04:30AM
Source: On The Move News on Seeking Alpha (opens in new tab)